Skip to main content
. 2021 May 5;11(5):e049964. doi: 10.1136/bmjopen-2021-049964

Table 1.

Assessments and timepoints

Study timepoints Prescreen ing Baseline Day 1 Day 2 Day 3 Day 4 Day 5 Days 5–8 Days 5–28 (as applicable) Day 28
Prescreening X
Informed consent X
Eligibility criteria X
Eligibility review if change in health information X
Randomisation/treatment allocation X
Baseline case report form X
Nose swab collection (if child remains unwell) X X X X X
Nose swab return X
Intervention arm—HS drops X X X X X X
Daily diary X X X X X X
Adverse events X X X X X X
End of illness diary graphic file with name bmjopen-2021-049964ilf93.jpg
Satisfaction questionnaire graphic file with name bmjopen-2021-049964ilf13.jpg
Return of diaries X
Day 28 wheeze question X

HS, hypertonic saline.